Dariohealth 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Dariohealth in the second quarter 2026?
Dariohealth Corp achieved a return on average equity (ROE) of 12217.88 % in its second quarter 2026 a new company high.

ROE has advanced compared to 60.52% in the first quarter 2026, due to net income growth.

Within the Medical Equipment & Supplies industry Dariohealth Corp achieved the highest return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 97 to 162.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	-13.91 %	-15.36 %	-5.69 %	28.07 %	-
Y / Y Net Income Change	60899.02 %	-10.6 %	-6.24 %	-15.12 %	-4.56 %
Net Income (TTM) in Millions	7,952	41	42	42	44
Return On Equity (TTM)	12217.88 %	60.52 %	59.48 %	59.47 %	65.89 %
DRIO's Total Ranking	# 162	# 97	# 114	# 122	# 93
Equity (TTM) in Millions	55	62	68	75	64
Seq. Equity Change	-11.69 %	-8.16 %	-9.36 %	17.11 %	-13.18 %
Seq. Net Income Change	95957.38 %	-8.66 %	-13.71 %	-19.43 %	40.78 %

Back to DRIO Management Effectiveness >> DRIO's 5 Years Annual ROE >> Compare DRIO ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	# 162

Return On Equity Statistics
High	Average	Low
12217.88 %	195.76 %	-439.94 %
(Jun 30 2026)		(Sep 30 2017)

DRIO Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	68	72	58	80	86
Y / Y Equity Change	-5.69 %	23.86 %	-27.32 %	-6.49 %	203.89 %
Net Income in Millions	42	43	59	62	79
Y / Y Net Income Change	-2.42 %	-28.07 %	-4.45 %	-21.04 %	-
Return On Equity	61.41 %	59.36 %	102.21 %	77.74 %	92.07 %

Back to DRIO Management Effectiveness >> DRIO's 5 Years Annual ROE >> Compare DRIO ROE to its Competitors

Annual Roe Comment

Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 61.41 % compared to the prior year.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DRIO's' Return on Equity at Yahoo Finance
DRIO's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DRIO's Competitors
Subscribers only: Roe for Dariohealth 's Suppliers
Subscribers only: Return On Equity for DRIO's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
Dariohealth Corp	12,217.88 %

Date modified: 2026-09-26T07:11:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.